To test the hypothesis that an angiotensin-receptor blocker (ARB), either alone or combined with an ACE inhibitor, is more effective than an ACE inhibitor alone in high-risk patients after MI ...
Routine use of angiotensin-converting-enzyme (ACE) inhibitors or angiotensin-receptor blockers (ARBs) is recommended in proteinuric nontransplant kidney disease patients, to reduce proteinuria and ...
A recent study suggests that a commonly prescribed type of blood pressure medication, known as angiotensin receptor blockers ...
Large secondary prevention trials suggest that dual RAS blockade is not generally indicated for the prevention of CHF in Stage A/B patients, since ARBs and ACE inhibitors are equal with respect to ...
Prophylactic cardiac treatment may prolong survival in Duchenne muscular dystrophy (DMD), but only one-quarter of individuals ...
Getting kidney patients to stick with an angiotensin-converting enzyme inhibitor (ACEI) or angiotensin receptor blocker (ARB) presents a real challenge. Here are some tips that may help.
Getting kidney patients to stick with an angiotensin-converting enzyme inhibitor (ACEI) or angiotensin receptor blocker (ARB) presents a real challenge. Here are some tips that may help.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback